Goldman Sachs’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $128K | Buy |
|
|||||
|
2025
Q1 | $124K | Sell |
|
|||||
|
2024
Q4 | $170K | Buy |
|
|||||
|
2024
Q3 | $172K | Buy |
|
|||||
|
2024
Q2 | $298K | Buy |
|
|||||
|
2024
Q1 | $87.3K | Sell |
|
|||||
|
2023
Q4 | $78.6K | Sell |
|
|||||
|
2023
Q3 | $274K | Buy |
|
|||||
|
2023
Q2 | $103K | Sell |
|
|||||
|
2023
Q1 | $880K | Buy |
|
|||||
|
2022
Q4 | $107K | Buy |
|
|||||
|
2022
Q3 | $74K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $11K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $169K | Sell |
|
|||||
|
2015
Q2 | $367K | Buy |
|